Literature DB >> 9223067

Stability of cortical self-regulation in epilepsy patients.

B Kotchoubey1, V Blankenhorn, W Fröscher, U Strehl, N Birbaumer.   

Abstract

Biofeedback-supported self-regulation of slow cortical potentials (SCP) is increasingly being used for treatment of intractable epilepsy. However, it is unknown whether the acquired ability to regulate one's own cortical potentials remains stable over time. In this study, 18 patients with drug-resistant partial epilepsy performed 35 training sessions in which they learned to generate slow cortical potential shifts in either positive or negative direction. At the end of training, they differentiated significantly between required cortical positivity and required cortical negativity. Six months after this point, they still demonstrated an unchanged between-condition differentiation. The performance in the booster session was particularly good in trials without continuous SCP feedback. The ability to generate positive SCP shifts was related to decrease of seizure frequency during the 6 months follow-up period compared with the 3 month baseline period. This data indicate that the acquired ability of humans to regulate their cortical potentials did not decrease over a 6 month period but rather, tended to consolidate.

Entities:  

Mesh:

Year:  1997        PMID: 9223067     DOI: 10.1097/00001756-199705260-00015

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

Review 1.  Science, medicine, and the future: functional magnetic resonance imaging in neuropsychiatry.

Authors:  C Longworth; G Honey; T Sharma
Journal:  BMJ       Date:  1999-12-11

2.  Brain areas activated in fMRI during self-regulation of slow cortical potentials (SCPs).

Authors:  Thilo Hinterberger; Ralf Veit; Ute Strehl; Tracy Trevorrow; Michael Erb; Boris Kotchoubey; Herta Flor; Niels Birbaumer
Journal:  Exp Brain Res       Date:  2003-06-27       Impact factor: 1.972

Review 3.  Biofeedback and epilepsy.

Authors:  Yoko Nagai
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

4.  Neurofeedback impacts cognition and quality of life in pediatric focal epilepsy: An exploratory randomized double-blinded sham-controlled trial.

Authors:  Leon Morales-Quezada; Diana Martinez; Mirret M El-Hagrassy; Ted J Kaptchuk; M Barry Sterman; Gloria Y Yeh
Journal:  Epilepsy Behav       Date:  2019-11-08       Impact factor: 2.937

5.  Time course of clinical change following neurofeedback.

Authors:  Mariela Rance; Christopher Walsh; Denis G Sukhodolsky; Brian Pittman; Maolin Qiu; Stephen A Kichuk; Suzanne Wasylink; William N Koller; Michael Bloch; Patricia Gruner; Dustin Scheinost; Christopher Pittenger; Michelle Hampson
Journal:  Neuroimage       Date:  2018-05-02       Impact factor: 6.556

Review 6.  Are treatment effects of neurofeedback training in children with ADHD related to the successful regulation of brain activity? A review on the learning of regulation of brain activity and a contribution to the discussion on specificity.

Authors:  Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Front Hum Neurosci       Date:  2015-03-27       Impact factor: 3.169

7.  Sustained reduction of seizures in patients with intractable epilepsy after self-regulation training of slow cortical potentials - 10 years after.

Authors:  Ute Strehl; Sarah M Birkle; Sonja Wörz; Boris Kotchoubey
Journal:  Front Hum Neurosci       Date:  2014-08-08       Impact factor: 3.169

8.  Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects.

Authors:  Ute Strehl; Pascal Aggensteiner; Daniel Wachtlin; Daniel Brandeis; Björn Albrecht; Maria Arana; Christiane Bach; Tobias Banaschewski; Thorsten Bogen; Andrea Flaig-Röhr; Christine M Freitag; Yvonne Fuchsenberger; Stephanie Gest; Holger Gevensleben; Laura Herde; Sarah Hohmann; Tanja Legenbauer; Anna-Maria Marx; Sabina Millenet; Benjamin Pniewski; Aribert Rothenberger; Christian Ruckes; Sonja Wörz; Martin Holtmann
Journal:  Front Hum Neurosci       Date:  2017-03-31       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.